Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 12/30/2024NMPA Announces Package Insert Revision of Potassium Bismuth Citrate Gr...
  • 12/30/2024Solasia Struggles to Finalize China Deal, Lowers 2024 Financial Guidan...
  • 12/30/2024 India Deepens Ties with Chinese Biotech: Cipla and Mankind Lead the W...
  • 12/30/2024TEVIMBRA Approved in the U.S. as First-line Treatment of G/GEJ in Com...
  • 12/29/2024CSRC Approves Ascentage Pharma's U.S. IPO Filing
  • 12/29/2024Hong Kong Accepts IPO Application from GenFleet Therapeutics
  • 12/29/2024IDEAYA Biosciences Enters Exclusive License with Hengrui Pharma for AD...
  • 12/27/2024Recent Executive Moves
  • 12/27/2024AusperBio Secures $73M in Series B Financing to Advance Functional Cur...
  • 12/27/2024CDE Issues the List of Reference Formulations for GQCE Studies (87th B...
  • 12/27/2024Collaborative Governance Mechanism for Healthcare, Medical Insurance, ...
  • 12/27/2024China's Commercial Health Insurance: Growth Trends and Challenges in C...
  • 12/27/2024China's Innovative Drug Approvals in 2024 and Blockbusters Anticipated...
  • 12/27/2024Review of China's Hospital Drug Market: Strong Competition Amid Slight...
  • 12/26/2024Alphamab Initiates Phase I/II Trial for HER2 ADC Bispecific and PD-L1 ...
  • 12/25/2024Huaota Biopharma Secures CNY 200M in Financing to Drive R&D
  • 12/25/2024Hechuang Biotech Secures Series A Funding to Advance CGT Research
  • 12/25/2024Eli Radiopharma Raises Funds to Accelerate Radiopharma Innovations
  • 12/25/2024Auzone Submits NDA for TTYP01 to FDA, Anticipates 2025 Approval
  • 12/25/2024China NMPA Accepts NDA for ARS Pharma's Epinephrine Nasal Spray
  • 12/25/2024NMPA Announces Package Insert Revision of Human Tetanus Immunoglobulin...
  • 12/24/2024Sanofi Reaffirms Commitment to China's Growing Biopharmaceutical Secto...
  • 12/24/2024Fosun Pharma's Parent Company Pledges 27% of Its A-shares
  • 12/24/2024WuXi Biologics to Divest Advanced Therapies Unit Amid U.S. Restriction...
  • 12/24/2024State Council Moves to Advance Pharma Reforms and Regulatory Streamlin...
  • 12/24/2024Roche's Lunsumio (Mosunetuzumab) Gains NMPA Approval for r/r Follicula...
  • 12/24/2024 Ascentage Pharma Secures Chinese Regulatory Approval for U.S. Nasdaq ...
  • 12/24/2024CDE Seeks Comments on the Supplementary List of External Experts for t...
  • 12/23/2024Ascelia Pharma Secures Chinese Patent for 2nd-Generation Orviglance
  • 12/23/2024RAPT Thera and Jemincare Enter License Deal for Novel Long-Acting an...
  • Page:35/55 Total number of articles:1645: [First][<<] [33] [34] [35] [36] [37] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group